Abstract
Mouse receptor activator of NF-κB ligand (RANKL), which induces osteoclastogenesis from monocytes or macrophages, was independently cloned by three groups in 1997. Mouse osteoclasts have been induced from peripheral monocytes stimulated by RANKL and macrophage colony-stimulating factor (M-CSF) both in vitro and in vivo; however, the mechanism of primate osteoclastogenesis has not been studied. In addition, the effects of human RANKL on primate osteoclastogenesis remain to be elucidated. Here, we investigated the effect of human RANKL on the osteoclastogenesis of monocytes from five subspecies of primates. Human RANKL induced osteoclastogenesis of all the primates. In addition, human RANKL induced pit formation by osteoclasts from monocytes of the crab-eating macaque. We also demonstrated that the primate osteoclastogenesis was inhibited by a novel peptide, which inhibited human osteoclastogenesis in our previous study. Thus, these findings clearly demonstrated that human RANKL induces primate osteoclastogenesis in the presence of human M-CSF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson D. M.; Maraskovsky E.; Billingsley W. L.; Dougall W. C.; Tometsko M. E.; Roux E. R.; Teepe M. C.; DuBose R. F.; Cosman D.; Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390: 175–179; 1997.
Fata J. E.; Kong Y. Y.; Li J.; Sasaki T.; Irie-Sasaki J.; Moorehead R. A.; Elliott R.; Scully S.; Voura E. B.; Lacey D. L.; Boyle W. J.; Khokha R.; Penninger J. M. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 103(1): 41–50; 2000.
Jones D. H.; Nakashima T.; Sanchez O. H.; Kozieradzki I.; Komarova S. V.; Sarosi I.; Morony S.; Rubin E.; Sarao R.; Hojilla C. V.; Komnenovic V.; Kong Y. Y.; Schreiber M.; Dixon S. J.; Sims S. M.; Khokha R.; Wada T.; Penninger J. M. Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 440(7084): 692–6; 2006.
Kong Y. Y.; Yoshida H.; Sarosi I.; Tan H. L.; Timms E.; Capparelli C.; Morony S.; Oliveira-dos-Santos A. J.; Van G.; Itie A.; Khoo W.; Wakeham A.; Dunstan C. R.; Lacey D. L.; Mak T. W.; Boyle W. J.; Penninger J. M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397: 315–323; 1999.
Kotake S.; Higaki M.; Sato K.; Himeno S.; Morita H.; Kim K. J.; Nara N.; Miyasaka N.; Nishioka K.; Kashiwazaki S. Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. J. Rheumatol. 19: 1511–1516; 1992.
Kotake S.; Nanke Y.; Kawamoto M.; Yago T.; Udagawa N.; Ichikawa N.; Kobashigawa T.; Saito S.; Momohara S.; Kamatani N.; Yamanaka H. T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis. Bone. 45: 627–639; 2009a.
Kotake S.; Nanke Y.; Yago T.; Kawamoto M.; Yamanaka H. Human osteoclastogenic T cells and human osteoclastology. Arthritis Rheum. 60: 3158–3163; 2009b.
Kotake S.; Yago T.; Kawamoto M.; Nanke Y. Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial 'human osteoclastology'. J. Bone Miner. Metab. 30: 125–135; 2011.
Kotake S.; Yago T.; Kawamoto M.; Nanke Y. The role of T-cell leukemia translocation-associated gene protein in human tumorigenesis and osteoclastogenesis. J. Biomed. Biotechnol. 2012: 675317; 2012.
Lam J.; Nelson C. A.; Ross F. P.; Teitelbaum S. L.; Fremont D. H. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J. Clin. Invest. 108: 971–979; 2001.
Modderman W. E.; Tuinenburg-Bol Raap A. C.; Nijweide P. J. Tartrate-resistant acid phosphatase is not an exclusive marker for mouse osteoclasts in cell culture. Bone 12: 81–87; 1991.
Schramek D.; Leibbrandt A.; Sigl V.; Kenner L.; Pospisilik J. A.; Lee H. J.; Hanada R.; Joshi P. A.; Aliprantis A.; Glimcher L.; Pasparakis M.; Khokha R.; Ormandy C. J.; Widschwendter M.; Schett G.; Penninger J. M. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468(7320): 98–102; 2010.
Simonet W. S.; Lacey D. L.; Dunstan C. R.; Kelley M.; Chang M. S.; Lüthy R.; Nguyen H. Q.; Wooden S.; Bennett L.; Boone T.; Shimamoto G.; DeRose M.; Elliott R.; Colombero A.; Tan H. L.; Trail G.; Sullivan J.; Davy E.; Bucay N.; Renshaw-Gegg L.; Hughes T. M.; Hill D.; Pattison W.; Campbell P.; Sander S.; Van G.; Tarpley J.; Derby P.; Lee R.; Boyle W. J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309–319; 1997.
Suda T.; Takahashi N.; Udagawa N.; Jimi E.; Gillespie M. T.; Martin T. J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 120: 345–357; 1999.
Tsuda E.; Goto M.; Mochizuki S.; Yano K.; Kobayashi F.; Morinaga T.; Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234: 137–142; 1997.
Wong B. R.; Rho J.; Arron J.; Robinson E.; Orlinick J.; Chao M.; Kalachikov S.; Cayani E.; Bartlett III F. S.; Frankel W. N.; Lee S. Y.; Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25190–25194; 1997.
Yasuda H.; Shima N.; Nakagawa N.; Yamaguchi K.; Kinosaki M.; Mochizuki S.; Tomoyasu A.; Yano K.; Goto M.; Murakami A.; Tsuda E.; Morinaga T.; Higashio K.; Udagawa N.; Takahashi N.; Suda T. Osteoclast differentiation factor is a ligand for osteoprote-gerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597–3602; 1998.
Acknowledgments
This work was supported in part by a grant-in aid (2008-12) from the Ministry of Education, Science, Sports and Culture of Japan. We thank Ms. Hanae Kikuchi (Tokyo Women's Medical University) for her valuable technical assistance.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Kotake, S., Yago, T., Kawamoto, M. et al. Human receptor activator of NF-κB ligand (RANKL) induces osteoclastogenesis of primates in vitro. In Vitro Cell.Dev.Biol.-Animal 48, 593–598 (2012). https://doi.org/10.1007/s11626-012-9549-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-012-9549-1